Lack of Association Between the CCR5-delta32 Polymorphism and Neurodegenerative Disorders.
Alzheimer Dis Assoc Disord
; 34(3): 244-247, 2020.
Article
em En
| MEDLINE
| ID: mdl-31972607
ABSTRACT
OBJECTIVE:
Recent studies have suggested that diminished Ccr5 functioning has an effect on synaptic plasticity and hippocampal memory in mouse models. CCR5-delta32, a 32-bp frameshift deletion in human CCR5 encoding a nonfunctional receptor, has been reported to have a protective effect against human immunodeficiency virus infection but its role as a modifier of neurodegenerative disease has been minimally explored. We investigated whether the CCR5-delta32 polymorphism could have an effect in the context of human neurodegenerative diseases.METHODS:
We examined the frequency of the CCR5-delta32 polymorphism in a large and well-characterized cohort including 1425 patients with neurodegenerative dementias and 2032 controls.RESULTS:
We did not observe a significant association between the CCR5-delta32 polymorphism and any of the neurodegenerative diseases screened in this study. However, we observed an earlier age of onset among neurodegenerative disease patients carrying the CCR5-delta32 allele.CONCLUSIONS:
Although our findings were inconclusive, the earlier age of onset observed among neurodegenerative disease patients carrying the CCR5-delta32 allele suggests that the deletion may have a detrimental effect in the context of neurodegeneration.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Polimorfismo Genético
/
Idade de Início
/
Doenças Neurodegenerativas
/
Receptores CCR5
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article